<?xml version="1.0" encoding="UTF-8"?>
<ref id="bibr99-0300060519845488">
 <label>99</label>
 <mixed-citation publication-type="book">
  <collab>XOFLUZA</collab> (Baloxavir marboxil) for the treatment of influenza types A and B launched in Japan. 
  <italic>Shionogi press release</italic>
  <year>2018</year>.
 </mixed-citation>
</ref>
